Applied Materials has deepened its cross-industry collaboration by adding Broadcom and SCREEN Semiconductor Solutions to its EPIC platform to co-develop advanced chip packaging and wafer process solutions. This move aims to integrate customer and supplier R&D directly into its investment, accelerating materials engineering breakthroughs to manufacturing. While these partnerships could boost AI-driven tool demand, the article notes that investors should still consider risks like export controls and China exposure, which remain significant factors in the company's investment narrative.

Draganfly Inc. has strengthened its defense involvement by securing a development contract with DEVCOM Army Research Laboratory for a modular counter-unmanned aircraft system and introducing the Blitz EO/IR payload platform as an exclusive integrator for Blitz Technologies in the Americas. These strategic moves are expected to expand Draganfly’s role in ISR and force protection missions, potentially reshaping its investment narrative. While these developments align with the company's growth ambitions, investors should proceed with awareness of the risks associated with execution on large opportunities, reliance on government budgets, and the company’s history of losses and equity raises.

Alphabet Inc. has announced an $80 billion equity capital raise to significantly expand its AI infrastructure, including a $10 billion investment from Berkshire Hathaway. The funds will also cover Alphabet's 2026 tax obligations and streamline employee equity award tax handling. Berkshire Hathaway's investment further solidifies its position in Alphabet, coming after several investments since Q3 2025.

Allstate Corp. shares advanced 1.07% on Monday, breaking a four-day losing streak, but still underperformed compared to the broader market. The S&P 500 Index rose 0.26% and the Dow Jones Industrial Average gained 0.09% on the same day.

CVD Equipment Corp (CVV) shares are trading around their 200-day moving average near $6.00 on Nasdaq, indicating a period of consolidation. Despite modest trading volume and a lack of recent company news, the stock remains on investors' radar. The company, which specializes in semiconductor and advanced materials equipment, has no verified analyst coverage, making investor sentiment and broader sector trends key drivers for its stock performance.

Eikon Therapeutics has released its Q2 2026 update, highlighting significant progress in its clinical and preclinical pipeline, including promising clinical results for its TLR7/8, PARP1, and WRN inhibitors in oncology. The company is leveraging its proprietary single-molecule tracking technology and AI/ML platform to advance novel therapies, with multiple catalysts like data readouts and regulatory milestones expected in 2026. Despite a limited operating history and ongoing losses, Eikon's strong leadership and innovative approach position it as a company to watch for potential shareholder value impact.

Epsilon Energy Ltd. (NASDAQ: EPSN) declared a quarterly dividend of $0.0625 per share, payable on June 30, 2026, to shareholders of record by June 15, 2026. The company also announced that its borrowing base under its senior secured revolving credit facility has been redetermined at $90 million, with commitments increased to the same amount, effective May 29, 2026. Currently, $40.5 million is outstanding on the credit facility.

Las Vegas Sands Corp (LVS) stock rose 5.3% to $53.27, trading below its GF Value™ of $68.79, indicating it is "Modestly Undervalued" with a 22.6% margin of safety. The company has a strong GF Score™ of 85/100, particularly in profitability and valuation, despite a moderate financial strength rating and recent insider selling of $3.9 million worth of shares. While undervalued, investors should conduct due diligence given the year-to-date decline and insider selling trends.

Axon Enterprise Inc (AXON) shares surged 6.3% recently, bringing its year-to-date decline to 16.0% and its 52-week drop to 36.5%. The company holds a GF Score of 81/100, indicating strong overall quality and growth potential, and is currently deemed modestly undervalued by GuruFocus's GF Value™ at $476.88, 19.2% below its intrinsic value estimate. Despite the potential undervaluation, significant insider selling totaling $29.0 million over the last three months, with no reported buying, suggests caution for investors.

Paychex Inc (PAYX) shares recently gained 5.6% to close at $102.44. Despite this, the company appears significantly undervalued by 34.4% compared to its GF Value™ of $156.08, and holds a strong GF Score™ of 84/100, driven by high profitability and growth scores. However, a low momentum rank and an absence of insider buying activity over the last three months suggest investors should exercise caution.